B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens: Boston Friday, March 21, 2025, 15:00 Hrs [I ...

In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- ...

Roundtree Lab, LLC is a leader in AI-driven healthcare solutions, specializing in smart medical devices and patient transport innovations. By integrating artificial intelligence and automation, ...

New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaksBOSTON, ...

This graphic illustrates paracrine adhesion signaling on small extracellular vesicles, which secretes a protein called ...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs ...

Galectin-3; gliadin; gluten; intestinal mucosa; celiac disease; gut inflammation Given that galectin-3 suppressed mucosal inflammation and reduced the severity of experimental colitis (Tsai et al.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...